Neumora Therapeutics, Inc. Common Stock (NMRA)
Market Closed
22 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
0. 41
-0.01
-2.4039%
$
89.03M Market Cap
- P/E Ratio
- Div Yield
863,500 Volume
-1.75 Eps
$ 0.42
Previous Close 
Want to track NMRA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Neumora Therapeutics, Inc. Common Stock (NMRA) Statistics
Valuation metrics
Market Cap 89.03M
Enterprise value -27.47M
Trailing P/E (ttm) -0.39
Forward P/E -
PEG ratio -0.02
Price/Sales (ttm) -
Price/Book (mrq) 1.97
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.13
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.59M
Average volume (90 days) 1.37M
Price summary
52-Week low 0.32
52-Week high 3.65
Beta -
50-Day moving average 0.8
200-Day moving average 1.54
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.7%
Return on equity -2.42%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.15
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.63
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 4.5%
Book value per share (mrq) 0.24
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
